Last updated: 2026-11-13 13:20:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
CorMedix Inc. (CRMD) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.95, with a market capitalization of $384.67M and a P/E ratio of 2.06. Over the past 52 weeks, its price has ranged from $4.82 to $13.02. This page covers its latest market performance, valuation, price trends and company information.
$384.67M | |
$4.88 | |
$5.14 | |
$4.85 | |
$4.84 | |
4.05K | |
1.30M | |
2.06 | |
$13.02 | |
$4.82 | |
-- | |
-- |
CorMedix Inc. (CRMD) is trading at $4.95 in pre-market trading as of 2026-11-13 13:13:00, up 2.27% ($0.11) from the previous close of $4.84
Pre-market trading shows how investors are pricing CRMD before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
CRMD is down 3.60% in pre-market trading.
Over the past seven days, CorMedix Inc. (CRMD) moved from $5.23 to $4.95, representing a decline of 5.35% ($0.28).
The stock traded between $4.82 and $5.77 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.92 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.6%
CRMD is currently trading at $4.95, placing it 1.6% of the way from its 52-week low of $4.82 to its 52-week high of $13.02. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 191 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to CorMedix Inc. and CRMD stock.
Cormedix (NASDAQ:CRMD) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For
CorMedix (CRMD) reported a quarterly loss of $0.04 per share, beating consensus estimates of $0.09 loss by 55.56%, but revenues declined to $54.52 million from $104.28 million year-over-year. The stock has underperformed the market by 54.4% this year and carries a Zacks Rank #3 (Hold) rating. Techne (TECH), a peer in the medical testing industry, is expected to report earnings of $0.46 per share with modest revenue growth of 2.4%.
Cormedix (NASDAQ:CRMD) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.10) by 90 percent. This is a 133.33 percent decrease over earnings of $0.57 per share from the
Cormedix (NASDAQ:CRMD) affirms FY2026 sales outlook from $325.000 million-$345.000 million to $325.000 million-$345.000 million vs $337.061 million estimate.
Eligible investors can buy real shares of CorMedix Inc. (CRMD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
See US stocks with the highest market capitalization
Discover today's most actively traded US stocks
Browse today's leading gainers in the US stock market
Explore the cryptocurrencies with the highest market capitalization
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CRMD, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CRMD shares and USD.
CRMD Shares to USD
1.00 CRMD shares = 4.95 USD
Calculations are estimates based on the latest available price and are for reference only.
